In this article

JNJ

Follow your favorite stocks CREATE FREE ACCOUNT

In a Friday interview with CNBC's Jim Cramer , Johnson & Johnson CEO Joaquin Duato expressed optimism about the future of pharmaceutical innovation in the U.S., even as the Trump administration slaps tariffs on imported drugs and cuts research funding.

"We've been through ups and downs at Johnson & Johnson over our 140 years of history. I'm an optimist," Duato said. "I believe in the strength of the life science industry in this country. I think that we will remain the leaders as we are today, the undisputed leaders in healthcare innovation."

On Thursday, President Donald Trump announced the U.S. would impose a 100% tariff on "any branded or patented Pharmaceutical Product" entering the country, starti

See Full Page